logo biblio digital exactas
logo twitter logo instagram logo whatsapp logo mail

Navegar

Colección

Datos Estadísticas

Lista de

Immunotherapy
19
"Glycans Pave the Way for Immunotherapy in Triple-Negative Breast Cancer" (2018) Salatino, M.; Girotti, M.R.; Rabinovich, G.A. Cancer Cell. 33(2):155-157
"Glycans Pave the Way for Immunotherapy in Triple-Negative Breast Cancer" (2018) Salatino, M.; Girotti, M.R.; Rabinovich, G.A. Cancer Cell. 33(2):155-157
"Immune-mediated and hypoxia-regulated programs: Accomplices in resistance to anti-angiogenic therapies" (2018) Croci, D.O.; Mendez-Huergo, S.P.; Cerliani, J.P.; Rabinovich, G.A. Handbook of Experimental Pharmacology. 249:31-61
"Immunotherapy in cancer. Current prospects, challenges and new horizons. " (2018) Dalotto-Moreno, T.;Blidner, A.G.;Girotti, M.R. (...)Rabinovich, G.A. Medicina (Argentina). 78(5):336-348
"Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways" (2016) Rabinovich, G.A.; Conejo-García, J.R. Journal of Molecular Biology. 428(16):3266-3281
"The thyroid hormone triiodothyronine reinvigorates dendritic cells and potentiates anti-tumor immunity" (2016) Alamino, V.A.; Montesinos, M.M.; Rabinovich, G.A.; Pellizas, C.G. OncoImmunology. 5(1)
"Antitumor responses stimulated by dendritic cells are improved by triiodothyronine binding to the thyroid hormone receptor β" (2015) Alamino, V.A.;Mascanfroni, I.D.;Montesinos, M.M. (...)Pellizas, C.G. Cancer Research. 75(7):1265-1274
"Antitumor responses stimulated by dendritic cells are improved by triiodothyronine binding to the thyroid hormone receptor β" (2015) Alamino, V.A.;Mascanfroni, I.D.;Montesinos, M.M. (...)Pellizas, C.G. Cancer Research. 75(7):1265-1274
"Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment" (2014) Croci, D.O.;Cerliani, J.P.;Pinto, N.A. (...)Rabinovich, G.A. Glycobiology. 24(12):1283-1290
"Comparative study of subcutaneous versus intravenous IgG replacement therapy in pediatric patients with primary immunodeficiency diseases: A multicenter study in Argentina" (2013) Bezrodnik, L.;Gómez Raccio, A.;Belardinelli, G. (...)Di Giovanni, D. Journal of Clinical Immunology. 33(7):1216-1222
"Disease-modifying immunotherapy for the management of autoimmune diabetes" (2010) Castro, C.N.;Barcala Tabarrozi, A.E.;Noguerol, M.A. (...)Perone, M.J. NeuroImmunoModulation. 17(3):173-176
"Disease-modifying immunotherapy for the management of autoimmune diabetes" (2010) Castro, C.N.;Barcala Tabarrozi, A.E.;Noguerol, M.A. (...)Perone, M.J. NeuroImmunoModulation. 17(3):173-176
"Overcoming the hurdles of tumor immunity by targeting regulatory pathways in innate and adaptive immune cells" (2010) Zwirner, N.W.; Croci, D.O.; Domaica, C.I.; Rabinovich, G.A. Current Pharmaceutical Design. 16(3):255-267
"Overcoming the hurdles of tumor immunity by targeting regulatory pathways in innate and adaptive immune cells" (2010) Zwirner, N.W.; Croci, D.O.; Domaica, C.I.; Rabinovich, G.A. Current Pharmaceutical Design. 16(3):255-267
"Tamm-Horsfall protein excretion to predict the onset of renal insufficiency" (2002) Romero, M.C.;Zanaro, N.;González, L. (...)Nesse, A. Clinical Biochemistry. 35(1):65-68
"Immunological mechanisms involved in the pathogenesis of multiple sclerosis " (2000) Correale, J. Revista de Neurologia. 31(5):471-476
"Amyotrophic lateral sclerosis IgG-treated neuromuscular junctions develop sensitivity to L-type calcium channel blocker" (2000) Fratantoni, S.A.;Weisz, G.;Pardal, A.M. (...)Uchitel, O.D. Muscle and Nerve. 23(4):543-550
"Immunotherapy of auto-immune diseases by gene transfer" (1999) Chernajovsky, Y.;Gould, D.;Annenkov, A. (...)Podhajcer, O. Biochemical Society Transactions. 27(6):869-873